MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$64,362K
Net Income
-$14,840K
Net Profit Margin
-23.06%
EPS
-$0.1
Unit: Thousand (K) dollars
Revenue Breakdown
Surgical
Wound
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net sales
64,362
17,368
118,095
113,725
Cost of sales
19,981
-
19,055
18,719
Gross profit
44,381
41,623
99,040
95,006
Impairment of intangible assets
-
0
0*
0
Investigation, restatement and related
-
0
-
0
Selling, general and administrative
59,779
53,231
73,073
69,001
Research and development
2,777
4,140
4,763
3,703
Investigation, restatement and related
-
-
0*
-
Amortization of intangible assets
291
301
128
112
Operating income
-18,466
-16,049
21,076
22,190
Interest income, net
788
886
904
785
Other expense, net
-102
-168
-186
-126
(loss) income before income tax
-17,780
-15,331
21,794
22,849
Income tax benefit (provision)
-2,940
-4,471
6,605
6,101
Net income from continuing operations
-
-10,860
15,189
16,748
Income from discontinued operations, net of tax
-
0
0
0
Net (loss) income
-14,840
-10,860
15,189
16,748
Basic EPS
-0.1
-0.07
0.103
0.11
Diluted EPS
-0.1
-0.07
0.101
0.11
Basic Average Shares
147,795,741
148,446,017
148,103,337
148,035,283
Diluted Average Shares
147,795,741
148,446,017
150,189,642
149,713,653
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net (loss) income
-$14,840K
(-254.29%↓ Y/Y)
Income tax benefit
(provision)
-$2,940K
(-186.75%↓ Y/Y)
Surgical
$39,297K
(15.14%↑ Y/Y)
Wound
$25,065K
(-61.13%↓ Y/Y)
(loss) income before
income tax
-$17,780K
(-236.70%↓ Y/Y)
Interest income, net
$788K
(6.78%↑ Y/Y)
Net sales
$64,362K
(-34.73%↓ Y/Y)
Operating income
-$18,466K
(-249.28%↓ Y/Y)
Gross profit
$44,381K
(-44.47%↓ Y/Y)
Other expense, net
-$102K
(-0.99%↓ Y/Y)
Cost of sales
$19,981K
(6.96%↑ Y/Y)
Selling, general and
administrative
$59,779K
(-6.82%↓ Y/Y)
Research and development
$2,777K
(-15.92%↓ Y/Y)
Amortization of intangible
assets
$291K
(191.00%↑ Y/Y)
Buy us a coffee
MIMEDX GROUP, INC. (MDXG)
MIMEDX GROUP, INC. (MDXG)